TAVEXIA LIFECARE LIMITED (539519)
🎯 Key Takeaways
- TAVEXIA LIFECARE LIMITED appears to be a micro-cap entity in the services/trading space, currently trading at a low valuation (P/E 20.2) but with negative ROE and ROCE, suggesting operational and profitability challenges.
- Revenue declined 92.5% QoQ to ₹1 in Q1FY27.
- ⚠️ 1) Persistent operational losses and negative margins in recent quarters pose a significant sustainability risk. 2) The company's shift from profitabi
📖 The Story
TAVEXIA LIFECARE LIMITED appears to be a micro-cap entity in the services/trading space, currently trading at a low valuation (P/E 20.2) but with negative ROE and ROCE, suggesting operational and profitability challenges. The company has shown volatile financial performance over the past year, with recent quarters alternating between minor gains and losses. Despite a 21.69% one-year return, underlying fundamentals remain weak, indicating speculative price movement rather than sustained value creation.
📰 What's Happening
Management has not announced any major strategic shifts or new business initiatives in the latest filings. The company continues to operate with minimal revenue generation, reporting ₹1 revenue in June 2026 and a loss of ₹7 in operating profit in March 2026. There has been no mention of new contracts, partnerships, or expansion plans in recent BSE filings. The business appears to be in a state of suspended activity, with no significant capital expenditure or operational upgrades disclosed.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 17 | 6 | 9 | 1 |
| Operating Profit | 1 | -1 | -7 | -0 |
| OPM % | 6.1% | -12.3% | -78.9% | -59.4% |
| Net Profit | 1 | -1 | -1 | -0 |
| EPS | ₹0.09 | ₹-0.02 | ₹-0.02 | ₹0.00 |
The company's financial trajectory shows a sharp decline from profitability in September 2025 (₹17 revenue, ₹1 profit) to consecutive quarterly losses in December 2025 and March 2026. Operating margins have deteriorated significantly, turning negative and widening in recent quarters. This reversal in performance suggests that prior improvements were not sustainable, and current operations are not generating sufficient returns to cover costs.
🔮 Management Outlook & What's Next
There is no forward guidance or explicit outlook provided by management in the latest regulatory filings. The company has not issued any earnings projections, strategic roadmap, or commentary on future growth prospects in the recent quarterly results or management discussion sections.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 12 | 19 | 38 | 38 |
| Reserves | 11 | 5 | 1 | 5 |
| Borrowings | 0 | 1 | 1 | 4 |
| Total Liabilities | 25 | 27 | 112 | 111 |
| Fixed Assets | 1 | 1 | 4 | 4 |
| Investments | 11 | 11 | 12 | 13 |
| Total Assets | 25 | 27 | 112 | 111 |
The balance sheet shows a modest increase in equity and assets over the past year, with total assets growing from ₹27 crore in March 2025 to ₹112 crore in March 2026. However, this growth appears to be driven by revaluation or reclassification rather than operational expansion, as borrowings remain minimal (₹4 crore) and reserves have only slightly increased. There is no evidence of aggressive investment or capital deployment.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +0 |
| Investing | -0 |
| Financing | +0 |
| Net Cash Flow | -0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 6.4% | 6.4% | 6.4% | 6.4% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 74.2% | 76.8% | 73.5% | 72.5% |
| # Shareholders | 35,984 | 37,375 | 36,620 | 35,910 |
Promoter holding remains stable at approximately 6.4%, with no signs of increase or reduction. Public shareholding has fluctuated slightly, but institutional ownership (FII/DII) remains negligible at 0%. The number of shareholders has gradually increased, suggesting retail investor interest, but lack of institutional participation indicates limited confidence from professional investors.
⚖️ Peer Comparison — Trading
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| ADANIENT | 3.95 L Cr | 45.3 | 10.9% | 9.1% | 1.09 |
| PREMIERENE | 46,303 | 27.4 | 50.0% | 59.3% | 0.67 |
| AEGISLOG | 44,419 | 35.5 | 24.6% | 24.4% | 0.40 |
| REDINGTON | 28,003 | 16.5 | 18.4% | 14.8% | 0.26 |
| HONASA | 15,677 | 62.9 | 28.3% | 21.1% | 0.00 |
| 504346 | 11,409 | — | -24.9% | -47.5% | 0.73 |
| LLOYDSENT | 11,031 | 36.0 | 7.0% | 5.7% | 0.17 |
| SGMART | 10,131 | 81.4 | 11.2% | 7.8% | 0.14 |
| MMTC | 9,345 | 20.9 | 42.4% | 26.3% | 0.00 |
| EBGNG | 6,975 | 49.5 | 31.3% | 62.9% | 1.92 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Persistent operational losses and negative margins in recent quarters pose a significant sustainability risk. 2) The company's shift from profitability to recurring losses lacks a clear explanation in management commentary. 3) Absence of institutional or DII interest suggests limited market confidence. 4) Low trading liquidity and micro-cap volatility could lead to sharp price swings without fundamental support.
🧠 Analyst's Read
TAVEXIA LIFECARE LIMITED is currently trading on speculative momentum rather than fundamentals, with no clear path to profitability in sight. Investors should monitor for any shift in operational performance or management commentary that signals a turnaround strategy, but until then, the company remains highly uncertain with elevated execution and survival risks.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd